Search

New school year

Good planning and communication between families and schools is very important to ensure children are safe and supported. With the new school year underway, hear from our Social Work team with their top tips on managing the start of a new school year.

Research Newsletter Coming

The Rio Tinto Children's Diabetes Centre will soon launch a newsletter dedicated to informing the community, our global researchers and our

Medtronic 780G Exciting News!

Medtronic have announced the release of the new Medtronic pump – the 780G with Smartguard features.

Animas pump offer

Insulin pump company Ypsomed Australia has announced an offer for families currently using an Animas Vibe.

Camp volunteers needed

Diabetes WA is looking for volunteers to take part in the PMH and Diabetes WA Camp for 9 and 10 year olds in Hillarys in September.

Herieth Mboya

Herieth leverages analytics, medical and research skills to prepare input data for geospatial analyses, conduct analyses, and generate insights for MAP Dar.

Does adjunctive clindamycin have a role in Staphylococcus aureus bacteremia? A protocol for the adjunctive treatment domain of the S. aureus Network Adaptive Platform (SNAP) randomized controlled trial

The use of adjunctive antibiotics directed against exotoxin production in Staphylococcus aureus bacteremia (SAB) is widespread, and is recommended in many guidelines, but there is limited evidence underpinning this.

Early Oral Antibiotic Switch in Staphylococcus aureus Bacteraemia: The Staphylococcus aureus Network Adaptive Platform (SNAP) Trial Early Oral Switch Protocol

Staphylococcus aureus bloodstream infection is traditionally treated with at least 2 weeks of intravenous antibiotics in adults, 3-7 days in children, and often longer for those with complicated disease. The current practice of treating S. aureus bacteremia with prolonged IV antibiotics (rather than oral antibiotics) is based on historical observational research and expert opinion. Prolonged IV antibiotic therapy has significant disadvantages for patients and healthcare systems, and there is growing interest in whether a switch to oral antibiotics following an initial period of IV therapy is a safe alternative for clinically stable patients.

A Survey of Infectious Diseases and Microbiology Clinicians in Australia and New Zealand About the Management of Staphylococcus aureus Bacteremia

Significant variation in practice, particularly for patients with a severe disease phenotype and antibiotic-resistant profile

CDKL5 Publications

Publications from 2017 dating back to 2004 of CDKL5 researchers.